Advertisement

Some Uses of Tritium-Labeled Compounds in Pharmaceutical Research

  • J. F. Snell

Abstract

Some of the basic problems in medical research involve studies of the absorption, translocation, “mode of action” and excretion of drugs. A pharmaceutical firm producing products for the medical profession is heavily concerned with the detailed biochemistry of its products. As criteria for acceptance and rejection of drugs become more refined, more energy will be expended in studying the precise biochemical handling of drugs. Important tools for such studies are labeled drugs and labeled metabolites.

Keywords

Tracer Isotope Liquid Scintillation Spectrometer Tetracycline Antibiotic Biological Stability Tracer Compound 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. (1).
    Snell, J. F., Wagner, R. L., Jr., and Hochstein, F. A. “Radioactive Oxytetracycline (Terramycin). I. Mode of Synthesis and Properties of the Radioactive Compound,” International Conf. on the Peaceful Uses of Atomic Energy 12, 431 (1955).Google Scholar
  2. (2).
    Snell, J. F., Garkuscha, R., and Allen, E. L. “Radioactive Oxytetracycline (Terramycin). II. Distribution in C-57 Mice (Preliminary Experiments),” Antibiotics Annual 1957–58, Medical Encyclopedia, Inc., New York (1958).Google Scholar
  3. (3).
    Snell, J. F., and Garkuscha, R. “Radioactive Oxytetracycline. III. Effect of Glucosamine HC1 on Serum Concentrations,” Proc. Soc. Exptl. Biol. and Medicine 98, 148 (1958).Google Scholar
  4. (4).
    Snell, J. F., and Allen, E. L. “Radioactive Oleandomycin. I. Preparation of Tritiated Oleandomycin for Biological Studies ” Unpublished data.Google Scholar
  5. (5).
    Snell, J. F., and Pellett, C. “Radioactive Oleandomycin. II. Preliminary Distribution and Excretion Studies of Tritiated Oleandomycin in Sprague-Dawley Rats.” Unpublished data.Google Scholar
  6. (6).
    Wilzbach, K. E. J. Am. Chem. Soc. 79, 1013 (1957).CrossRefGoogle Scholar
  7. (7).
    Werbin, H. J. Clin. Endocrin. Metab. 17, 337 (1957).CrossRefGoogle Scholar
  8. (8).
    André, T. “Studies on the Distribution of Tritium-Labeled Dihydrostreptomycin and Tetracycline in the Body,” Acta Radiologica (Supplementum 142 ) (1956).Google Scholar
  9. (9).
    Kazenko, A. “Physiologic Disposition of Oleandomycin in Animals,” Antibiotics and Chemotherapy 7, 410 (1957).Google Scholar
  10. (10).
    Snell, J. F., Thanassi, F.Z., and Sypowicz, D.A. “Studies in Metabolic Spectra. I. Mode of Action of Tetracycline Antibiotics,” Antibiotics and Chemotherapy. Feb. (1958).Google Scholar
  11. (11).
    Snell, J. F., and Cheng, L. “Studies in Metabolic Spectra. II. Application of Metabolic Spectra to the Investigation of the Mode of Action of Oxytetracycline (Terramycin),” Antibiotics Annual 1957–58, Medical Encyclopedia, Inc., New York (1958).Google Scholar

Copyright information

© New England Nuclear Corporation 1963

Authors and Affiliations

  • J. F. Snell
    • 1
  1. 1.Pfizer Therapeutic InstituteMaywoodUSA

Personalised recommendations